UK markets closed

Immunovia AB (publ) (IMMNOS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
4.3450-0.0950 (-2.14%)
At close: 04:24PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-260,727
-309,439
-168,092
-155,966
-146,033
-
Depreciation & amortisation
-
141,719
24,913
19,063
9,763
-
Change in working capital
11
7,134
-7,154
-5,338
4,532
-
Inventory
1,995
1,995
438
-2,038
0
-
Other working capital
-176,032
-148,118
-177,206
-176,832
-168,199
-
Net cash provided by operating activities
-174,971
-147,057
-175,582
-152,648
-120,704
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-1,061
-1,624
-24,184
-47,495
-
Purchases of investments
-
-
-
-
-
0
Other investing activities
-
2,929
-
-
-
-
Net cash used for investing activities
-296
3,197
-1,624
-23,826
-46,958
-
Net change in cash
-17,299
-29,117
-182,313
-181,743
205,918
-
Cash at beginning of period
68,237
106,041
287,406
468,462
263,345
-
Cash at end of period
7,744
76,788
106,041
287,406
468,462
-
Free cash flow
Operating cash flow
-174,971
-147,057
-175,582
-152,648
-120,704
-
Capital expenditure
-
-1,061
-1,624
-24,184
-47,495
-
Free cash flow
-176,032
-148,118
-177,206
-176,832
-168,199
-